<unk>  occurs most often in Caucasians between 60 and 80 years of age. Its incidence is about twice as high in males as in females. It is a rare type of skin cancer, with a 2013 incidence of only 0.7 per 100,000 persons in the U.S. As of 2005, roughly 2,500 new cases of<unk>  are diagnosed each year in the United States, as compared to around 60,000 new cases of malignant melanoma and over 1 million new cases of nonmelanoma skin cancer. Similar to melanoma, the incidence of<unk>  in the US is increasing rapidly. Worldwide,<unk>  is most commonly found in regions with increased sun exposure. Australia is the country with the highest incidence of<unk>  but has a lower incidence of MCV-positive<unk>  than observed in other countries. Since 2006, it has been known that other primary cancers increase the risk of<unk>  significantly, especially in those with the prior multiple myeloma, chronic lymphocytic leukemia, and malignant melanoma. Immunosuppression including HIV infection or immunosuppressant therapy following organ transplant or for autoimmune disease can also increase the odds of developing<unk> .
Merkel-cell carcinoma
Basal-cell carcinoma
Lymphoepithelioma
Trichoepithelioma
Angiokeratoma
Onychomatricoma
Sebaceous carcinoma
Generalized trichoepithelioma